🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cancer (With or Without Metastasis)

A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer NCT06953999Phase 33 sites📍 Harbin📍 Shanghai📍 Hangzhou Akeso · Tests: Ivonescimab, AK117, Albumin-bound Paclitaxel, Gemcitabine, Ivonescimab, AK117 Placebo, Albumin-bound Paclitaxel, Gemcit… A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer NCT07284849Phase 3293 sites📍 Mobile📍 Tucson📍 Tucson Incyte Corporation · Tests: INCA33890, Placebo, Bevacizumab, FOLFOX Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy in Patients Affected by Oligometastatic uRothelial carcinomA NCT07413523NA1 site📍 Rozzano Istituto Clinico Humanitas · Tests: SBRT The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal Cancer NCT07257653Phase 21 site📍 Hangzhou Zhejiang University · Tests: Cetuximab β；Fruquintinib；, Cetuximab β；Fruquintinib；anti-PD1 antibody；, Cetuximab β；Fruquintinib；anti-PD1/CTLA4 antibody A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer NCT05798819Phase 31 site📍 Shanghai Guangzhou Gloria Biosciences Co., Ltd. · Tests: GLS-010, Placebo, paclitaxel, cisplatin, carboplatin PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer NCT06086457Phase 31 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Radiation, TP or PF regimen depended on investigator's choice., PD-1 inhibitor Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients NCT05817903Phase 223 sites📍 Brescia📍 Candiolo📍 Catania Consorzio Oncotech · Tests: Axitinib, Nivolumab Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial NCT06563388Phase 31 site📍 Buffalo Roswell Park Cancer Institute · Tests: Stereotactic Ablative Radiotherapy, Best Practice A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer NCT06474468Phase 1, Phase 21 site📍 Jinan Shanghai Hengrui Pharmaceutical Co., Ltd. · Tests: SHR-A2102；Adebrelimab；Cisplatin Prospective Monocentric Study Evaluating the Circulating NK Cells Phenotype and the ImmunoScore® in Patients With Non Metastatic Rectal Cancer NCT06536127NA1 site📍 Avignon Institut Sainte Catherine · Tests: Blood samples A Prospective Study on the Diagnosis of Malignant Tumors With 18F-FGIn PET/CT NCT07602569n/a1 site📍 Guangzhou Affiliated Cancer Hospital & Institute of Guangzhou Medical… A Clinical Trial Comparing the Efficacy and Safety of Anyouping® and Platinum-based Chemotherapy With or Without Enlituo® in Advanced Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. NCT07791745Phase 2, Phase 31 site📍 Shanghai Taizhou Mabtech Pharmaceutical Co.,Ltd · Tests: Enlituo® + Anyouping® + PBC, Placebo-Enlituo + Anyouping® + PBC FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients NCT05727163Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Dexamethasone, Anisodamine, Oxaliplatin, Leucovorin, Fluorouracil Docetaxel or Cabazitaxel With or Without Darolutamide in mCRPC NCT05762536Phase 21 site📍 Rotterdam Erasmus Medical Center · Tests: Darolutamide, Docetaxel or cabazitaxel A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer NCT06512051Phase 1, Phase 21 site📍 Beijing Shanghai Hengrui Pharmaceutical Co., Ltd. · Tests: SHR-A2102 for Injection, Adebrelimab Injection, Cisplatin injection, Carboplatin injection, Bevacizumab Injection Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM NCT07728019Phase 21 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: SCRT, Retlirafusp alfa Injection, Bevacizumab, CAPOX Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer NCT05254171Phase 2, Phase 393 sites📍 Hot Springs📍 Fullerton📍 New Haven Panbela Therapeutics, Inc. · Tests: SBP-101, Nab-paclitaxel, Gemcitabine, Placebo PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer NCT07472153Phase 2, Phase 31 site📍 Minsk N.N. Alexandrov National Cancer Centre · Tests: PD-1 antibody, PD-L1 antibody, Chemotherapy and bevacizumab (CT-BEV) Adjuvant FOLFIRI Based-chemotherapy After Resection of CLM Responding to Preoperative FOLFIRI NCT06501482Phase 31 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Postoperative reintroduction of FOLFIRI based chemotherapy Andamertinib With or Without Platinum-doublet Chemotherapy Versus Platinum-doublet Chemotherapy in Patients With NSCLC Harboring Atypical EGFR Mutations NCT07336732Phase 21 site📍 Guangzhou Avistone Biotechnology Co., Ltd. · Tests: PLB1004 A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases NCT06136884Phase 16 sites📍 Detroit📍 Oklahoma City📍 Charleston A2A Pharmaceuticals Inc. · Tests: AO-252 Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation NCT06252649Phase 3291 sites📍 Chandler📍 Fullerton📍 Long Beach Amgen · Tests: FOLFIRI Regimen, Sotorasib, Panitumumab, Bevacizumab-awwb A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs) NCT06661915Phase 231 sites📍 Irvine📍 Orange📍 Palo Alto National Cancer Institute (NCI) · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Decitabine and Cedazuridine, Iadademstat A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors NCT03972657Phase 1, Phase 224 sites📍 Gilbert📍 Phoenix📍 Tucson Regeneron Pharmaceuticals · Tests: REGN5678, Cemiplimab Neoadjuvant Treatment of Fulzerasib Plus Cetuximab N01 in KRAS G12C Mutated Locally Advanced Colorectal Cancer With or Without Resectable Metastases NCT07581912Phase 21 site📍 Hangzhou Zhejiang University · Tests: fulzerasib; cetuximab N01 Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma NCT05978193Phase 22 sites📍 Shanghai📍 Shanghai Shanghai Chest Hospital · Tests: LDRT+CFRT, Immunotherapy, Chemotherapy A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors NCT06657144Phase 130 sites📍 Tucson📍 Duarte📍 Aurora Coherus Oncology, Inc. · Tests: CHS-114, Toripalimab, 5 Fluorouracil, Cisplatin Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors NCT07856394NA2 sites📍 Scottsdale📍 Rochester Mayo Clinic · Tests: Electronic Health Record Review, External Beam Radiation Therapy, Questionnaire Administration, Spatially-fractionated … FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer NCT07446322Phase 219 sites📍 Homewood📍 Beverly Hills📍 Encino Oncolytics Biotech · Tests: Bevacizumab, FOLFIRI, Pelareorep Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management. NCT07451483n/a1 site📍 Anderlecht Jules Bordet Institute
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy